196 related articles for article (PubMed ID: 22504623)
1. [Novel oral anticoagulants and their use in the perioperative setting].
Schellong SM; Haas S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Apr; 47(4):266-72; quiz 273. PubMed ID: 22504623
[TBL] [Abstract][Full Text] [Related]
2. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
3. Novel oral anticoagulants: implications in the perioperative setting.
Levy JH; Key NS; Azran MS
Anesthesiology; 2010 Sep; 113(3):726-45. PubMed ID: 20700042
[TBL] [Abstract][Full Text] [Related]
4. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
Becattini C; Vedovati MC; Agnelli G
Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
[TBL] [Abstract][Full Text] [Related]
5. [Perioperative management and therapy of bleeding complications].
von Heymann C; Kaufner L; Körber M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):196-204; quiz 205. PubMed ID: 24711240
[TBL] [Abstract][Full Text] [Related]
6. Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.
Sié P; Samama CM; Godier A; Rosencher N; Steib A; Llau JV; Van der Linden P; Pernod G; Lecompte T; Gouin-Thibault I; Albaladejo P; ;
Arch Cardiovasc Dis; 2011 Dec; 104(12):669-76. PubMed ID: 22152517
[TBL] [Abstract][Full Text] [Related]
7. Perioperative management of oral anticoagulation.
O'Donnell M; Kearon C
Clin Geriatr Med; 2006 Feb; 22(1):199-213, xi. PubMed ID: 16377475
[TBL] [Abstract][Full Text] [Related]
8. Old and new anticoagulants.
Harbrecht U
Hamostaseologie; 2011 Feb; 31(1):21-7. PubMed ID: 21311820
[TBL] [Abstract][Full Text] [Related]
9. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
10. Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.
Beyer-Westendorf J; Gelbricht V; Förster K; Ebertz F; Köhler C; Werth S; Kuhlisch E; Stange T; Thieme C; Daschkow K; Weiss N
Eur Heart J; 2014 Jul; 35(28):1888-96. PubMed ID: 24394381
[TBL] [Abstract][Full Text] [Related]
11. Peri-procedural management of patients taking oral anticoagulants.
Daniels PR
BMJ; 2015 Jul; 351():h2391. PubMed ID: 26174061
[TBL] [Abstract][Full Text] [Related]
12. Perioperative Management of Anticoagulation-Review of Latest Evidence.
Kannan A; Poongkunran C; Shenoy S; Abidov A
Am J Ther; 2016; 23(2):e474-84. PubMed ID: 26214205
[TBL] [Abstract][Full Text] [Related]
13. [Perioperative management of direct oral anticoagulants: not much evidence but several different approaches].
Stebelski L; Brichant JF; Piérard L; Peters P; Sénard M
Rev Med Liege; 2014 Dec; 69(12):671-9. PubMed ID: 25796785
[TBL] [Abstract][Full Text] [Related]
14. Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
Mar PL; Familtsev D; Ezekowitz MD; Lakkireddy D; Gopinathannair R
Int J Cardiol; 2016 Jan; 202():578-85. PubMed ID: 26447666
[TBL] [Abstract][Full Text] [Related]
15. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant management in the cardiovascular setting.
Verheugt FW
Fundam Clin Pharmacol; 2012 Feb; 26(1):11-5. PubMed ID: 21831129
[TBL] [Abstract][Full Text] [Related]
18. [New oral anticoagulants: recommendations, precautions and perspectives for use].
Di Minno G; Russolillo A; Ventre I; Di Minno A; Prisco D
G Ital Cardiol (Rome); 2012 Nov; 13(11 Suppl 1):28S-37S. PubMed ID: 23160017
[TBL] [Abstract][Full Text] [Related]
19. Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.
Ibrahim A; Walsh LG; Algaali M; Satti Z; Kiernan TJ; Yan BP
Expert Opin Pharmacother; 2019 Mar; 20(4):465-472. PubMed ID: 30521411
[TBL] [Abstract][Full Text] [Related]
20. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
